Prem Watsa’s Pfizer PFE Stock Holding History

Prem Watsa’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1M	Buy	1,043,900 +53,000	+5%	+$1.39M	0.95%	15
2026 Q1	$27.8M	Buy	990,900 +100,000	+11%	+$2.66M	1.43%	14
2025 Q4	$22.2M	Hold	890,900	–	–	1.06%	17
2025 Q3	$22.7M	Buy	890,900 +240,000	+37%	+$5.92M	1.1%	16
2025 Q2	$15.8M	Hold	650,900	–	–	0.84%	15
2025 Q1	$16.5M	Hold	650,900	–	–	0.89%	15
2024 Q4	$17.3M	Buy	650,900 +190,000	+41%	+$5.15M	1.11%	15
2024 Q3	$13.3M	Hold	460,900	–	–	1.21%	13
2024 Q2	$12.9M	Hold	460,900	–	–	1.09%	15
2024 Q1	$12.8M	Hold	460,900	–	–	1.04%	14
2023 Q4	$13.3M	Hold	460,900	–	–	0.9%	15
2023 Q3	$15.3M	Hold	460,900	–	–	0.82%	15
2023 Q2	$16.9M	Hold	460,900	–	–	0.9%	15
2023 Q1	$18.8M	Hold	460,900	–	–	1.07%	15
2022 Q4	$23.6M	Hold	460,900	–	–	0.59%	16
2022 Q3	$20.2M	Buy	460,900 +60,000	+15%	+$2.92M	0.52%	17
2022 Q2	$21M	Hold	400,900	–	–	0.74%	16
2022 Q1	$20.8M	Hold	400,900	–	–	0.69%	12
2021 Q4	$23.7M	Hold	400,900	–	–	0.76%	10
2021 Q3	$17.2M	Hold	400,900	–	–	0.56%	12
2021 Q2	$15.7M	Hold	400,900	–	–	0.51%	16
2021 Q1	$14.5M	Buy	400,900 +100,000	+33%	+$3.55M	0.51%	18
2020 Q4	$11.1M	Buy	+300,900	New	+$11M	0.49%	17
2018 Q1	–	Sell	-221,340	Closed	-$7.61M	–	46
2017 Q4	$7.61M	Hold	221,340	–	–	0.54%	12
2017 Q3	$7.49M	Hold	221,340	–	–	0.61%	12
2017 Q2	$7.05M	Hold	221,340	–	–	0.62%	13
2017 Q1	$7.18M	Hold	221,340	–	–	0.58%	13
2016 Q4	$6.82M	Hold	221,340	–	–	0.58%	14
2016 Q3	$7.11M	Hold	221,340	–	–	0.64%	11
2016 Q2	$7.39M	Hold	221,340	–	–	0.48%	12
2016 Q1	$6.22M	Hold	221,340	–	–	0.37%	14
2015 Q4	$6.78M	Sell	221,340 -26,350	-11%	-$829K	0.55%	13
2015 Q3	$7.38M	Hold	247,690	–	–	0.68%	11
2015 Q2	$7.88M	Hold	247,690	–	–	0.58%	11
2015 Q1	$8.18M	Hold	247,690	–	–	0.58%	11
2014 Q4	$7.32M	Hold	247,690	–	–	0.47%	11
2014 Q3	$6.95M	Hold	247,690	–	–	0.47%	13
2014 Q2	$6.97M	Hold	247,690	–	–	0.48%	12
2014 Q1	$7.55M	Hold	247,690	–	–	0.53%	11
2013 Q4	$7.2M	Hold	247,690	–	–	0.55%	12
2013 Q3	$6.75M	Hold	247,690	–	–	0.42%	13
2013 Q2	$6.59M	Buy	+247,690	New	+$6.84M	0.27%	18

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Prem Watsa's PFE Position: Q2 2026 in Review

Prem Watsa increased its Pfizer (PFE) stake by 5.3% in Q2 2026, buying an estimated $1.39M and bringing the position to 1,043,900 shares worth $25.1M. The position accounts for 0.95% of the portfolio, ranked #15.

Prem Watsa first reported a position in PFE in Q2 2013 and has held it in 42 quarters since. The position peaked at $27.8M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Prem Watsa held 1,043,900 shares of Pfizer worth $25.1M as of Q2 2026.
Prem Watsa bought 53,000 Pfizer shares in Q2 2026, an estimated $1.39M.
Pfizer made up 0.95% of Prem Watsa's portfolio in Q2 2026, its #15 holding.
Prem Watsa first reported a position in Pfizer in Q2 2013 and has held it in 42 quarters since.
Prem Watsa's Pfizer position peaked at $27.8M in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fairfax Financial Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.